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Hearing function is known to be heritable, but few significant and reproducible associations of genetic variants
have been identified to date in the adult population. In this study, genome-wide association results of hearing
function from the G-EAR consortium and TwinsUK were used for meta-analysis. Hearing ability in eight popula-
tion samples of Northern and Southern European ancestry (n 5 4591) and the Silk Road (n 5 348) was measured
using pure-tone audiometry and summarized using principal component (PC) analysis. Genome-wide associ-
ation analyses for PC1–3 were conducted separately in each sample assuming an additive model adjusted for
age, sex and relatedness of subjects. Meta-analysis was performed using 2.3 million single-nucleotide poly-
morphisms (SNPs) tested against each of the three PCs of hearing ability in 4939 individuals. A single SNP
lying in intron 6 of the salt-inducible kinase 3 (SIK3) gene was found to be associated with hearing PC2 (P 5
3.731028) and further supported by whole-genome sequence in a subset. To determine the relevance of this
gene in the ear, expression of the Sik3 protein was studied in mouse cochlea of different ages. Sik3 was
expressed in murine hair cells during early development and in cells of the spiral ganglion during early develop-
ment and adulthood. Our results suggest a developmental role of Sik3 in hearing and may be required for the
maintenance of adult auditory function.
INTRODUCTION
The human ear is one of the most delicate sensory organs of the
human body. The cascade of activity resulting in hearing ability
transduces the mechanical energy of sound into electrical sig-
nals. The inner ear includes the spiral-shaped cochlea containing
the organ ofCorti, the sensory structure that detects sound.Here,
stereocilia on the apical surface of sensory hair cells sense
movement of the surrounding fluids and open ion channels
upon stereocilia deflection. The resulting depolarization of the
hair cells initiates synaptic activity of auditory neurones. Inner
hair cells are innervated via mostly unbranched and myelinated
type I spiral ganglion neurones, whereas the rather thinner and
unmyelinated type II spiral ganglion neurones innervate outer
hair cells (1,2). Failure of any of the components may result in
impaired hearing ability or hearing loss (HL).
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Twin studies suggest a role for genetic factors in hearing
ability, with estimates of heritability of up to 70–75% (3–5).
Several environmental risk factors for diminished hearing
ability have been identified, including noise exposure (6,7), car-
diovascular disease (8), ototoxic medication (9) and smoking (7).
Genetic risk factors, for the most part, remain to be accurately
determined. Candidate gene studies have supported associations
of proteins involved in reactive oxygen species removal includ-
ing N-acetyl-transferase 2 (NAT2), glutathione S-transferase
theta 1 (GSST1) and glutathione S-transferase Mu 1 (GSTM1)
with presbycusis (10,11). Various studies have tried to elucidate
the genetic background of adult hearing function and age-related
HL in genome-wide linkage (12–14) and association studies
(14–17). In these studies, several genes involved in age-related
HL have been identified, including metabotropic glutamate re-
ceptor 7 (GRM7) and IQ motif containing GTPase activating
protein 2 (IQGAP2). Furthermore, a meta-analysis of hearing
function revealed associations with a series of genes including
metabotropic glutamate receptor 8 (GRM8) and protein tyrosine
phosphatase receptor type D (PTPRD) (17). However, confirm-
ation of findings or study of expression in model organisms has
been reported for only a few studies (15,17). Adult hearing is
likely to involve many common genetic variants each having
low effect sizes. In common with many complex traits, only a
small proportion of the heritability is explained by the genetic
variants identified so far.
In order to optimize power by maximizing sample size, we
performed a GWAS meta-analysis of eight European samples
and one Silk Road population sample (18), having hearing
ability measured by pure-tone audiometry and summarized by
principal components (PCs). Genetic variants found associated
with hearing ability were examined further for expression of
the gene product in mouse cochlear structures.
RESULTS
Subjects
The characteristics of the 4939 individuals are summarized by
sample in Table 1. Age for the different study samples ranged
from 18 to 98 years. There was a preponderance of female
participants (55%–100%) across the groups. Samples were
included from TwinsUK and the G-EAR consortium; the latter
were originally recruited to study hearing function in isolated
populations (19,20) and were collected from several isolated vil-
lages, as described previously (20). Samples from the TwinsUK
collection included same-sex twin pairs as part of a project to
study ageing. Principal component analysis was used to summar-
ize the pure-tone audiogram data (14). In TwinsUK, the first three
PCsof thepure-toneaudiogramaccounted for87%of thevariance
in the data. PC1 represented ameasure of the horizontal threshold
shift in the audiogram and, in TwinsUK, was highly correlated
with the pure-tone average calculated over all frequencies
(r ¼ 20.98). PC2 represented the downward slope of the audio-
gram reflecting worse thresholds at higher frequencies, and PC3
gaveameasureofaudiogramconcavity (howmuchtheaudiogram
deviates from a straight line). While PC1 values were negatively
correlated with raised pure-tone thresholds, high-frequency HL
(resulting in a downward slope from the lower to the higher fre-
quencies of the audiogram) was positively correlated with PC2.
Meta-analysis
Single-nucleotide polymorphisms (SNPs) most significantly
associated in GWAS meta-analysis of PC1, PC2 and PC3 are
shown in Tables 2, 3 and 4, respectively. After quality control
(described in Supplementary Material, Table S1) and imput-
ation, .2.3 million SNPs were examined. The complete set of
GWAS meta-analyses results can be accessed under following
link: http://www.twinsuk.ac.uk/wp-content/uploads/TUK_G-
EAR_GWAS_hearing.zip, last accessed on 7 July 2014. There
was a single genome-wide significant SNP (P , 5 × 1028) on
chromosome 11 associated with PC2, the PC representing the
slope for higher frequencies of the audiogram (Fig. 1, locus
zoom of SNP +400 kb). A forest plot of the results for this
SNP rs681524 is shown in Figure 2 with corresponding data in
Table 5. This plot shows the estimated effect sizes [beta and
95% confidence interval (CI)] of the C allele at rs681524 for
different samples and a combined meta-analysis effect (total
beta ¼ 20.24). The SNP was genotyped in TwinsUK and
imputed in the other samples but was not available in the
sample from Talana, so meta-analysis was performed on seven
Table 1. Population characteristics for subjects from the G-EAR consortium and TwinsUK
Population Country Sample size Gender (% females) Age range (years) Mean age (+ SD)
Carlantino Italy 280 56.87 18–89 53.29 (18.1)
Friuli Venezia Giulia Italy 1097 60.19 18–89 51.47 (16.3)
Korcula Croatia 804 63.30 18–98 56.3 (13.7)
Split Croatia 497 56.00 18–79 49.0 (14.6)
Cilento Italy 421 56.67 18–91 56.3 (17.6)
Talana Italy 470 59.00 18–92 50.82 (18.5)
Silk Road Azerbijan 348 54.60 18–82 41.59 (15.5)
Giorgia
Kazakistan
Tajikistan
Uzbekistan
Twins UK UK 1022 100 29–86 61.06 (9.1)
Total – 4939 – 18–98 –
Characteristics of the eight different populations by country of origin, sample size (n), gender and age range in years as well as mean age and standard deviation (SD)
from mean age.
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of the eight groups (n ¼ 4322).The forest plot showsaconsistent
direction of effect of this allele across all seven samples,which is
nominally significant in three of these (Split, Talana and
TwinsUK, Table 5). We further calculated the percentage of
total variation across the seven populations owing to heterogen-
eity in form of I2 (21). There was no observed heterogeneity
(I2 ¼ 0.0, P ¼ 0.481) for the association with rs681524. To
control for differences in allele frequency between the different
samples, data from the human genome diversity project (22)
were used. No significant differences could be detected for
rs681524 in the samples studied here. The locus zoom in
Figure 1 shows little in the way of supporting SNPs associated
with the hearing phenotype. Further evidence that this finding
was not a false-positive was sought: visual inspection of the
cluster plots of rs681524 in TwinsUK revealed clear separation
of the alleles (Supplementary Material, Table S2). Exploration
of the linkage disequilibrium (LD) pattern surrounding SNP
rs681524 (in a 1-Mb window surrounding rs681524) was made
using data from the 1000 Genomes Project (23) using the SNP
Annotation and Proxy Search tool (24) and the TwinsUK
cohort whole-genome sequencing sample as part of the
UK10K project. The data from the 1000 Genomes project con-
firmed that there were only 5 SNPs in moderate LD (r2 ¼ 0.8–
0.6) with rs681524, 4 of which were located in intronic regions
of the SIK3 gene and 1 SNP in an intron of the PCSK7 gene.
LD information calculated from the UK10K data revealed
even lower LD in the proximity of rs681524 (r2, 0.28 in 400
neighbouringSNPs inawindowof1 Mbsurrounding rs681524).
The accuracy of imputation of rs681524 in all samples but
from TwinsUK could be assessed in two samples from the
G-EAR consortium (Carlantino and Friuli Venezia Giulia),
subsets of which had whole-genome sequencing data available
in addition to the original imputation (Table 6). Imputation ac-
curacy accessed as genotype concordance at rs681524 ranged
Table 2. Meta-analysis results for PC1
SNP Allele 1 Allele 2 Z-score P-value direction Chr Position Gene Feature Left gene Right gene
rs589636 t c 25.40 6.61E-08 ?------? 13 76414577 IRG1 intron BTF3L1 LOC390413
rs588702 t c 25.33 9.75E-08 ?------- 13 76420926 IRG1 intron BTF3L1 LOC390413
rs2687481 t g 25.32 1.07E-07 -------? 7 125656358 NA NA LOC646837 GRM8
rs2521030 c g 25.23 1.69E-07 -------? 7 125656552 NA NA LOC646837 GRM8
rs614171 a g 25.23 1.71E-07 ?------- 13 76414753 IRG1 intron BTF3L1 LOC390413
FiveSNPswere suggestive genome-wide significant (P , 5 × 1027) associatedwith PC1.Meta-analysis results for PC1are further characterizedbynon-effect allele
(allele 1) and effect allele (allele 2), the resulting Z-score and significance of association (P-value). The direction of effect (minus or plus) is indicated for each of the
eight included populations. If an SNP did not pass QC criteria for a certain SNP, this is indicated by a questionmark (?) in the direction column.Mapping information
for eachSNP is specifiedby chromosome (chr), base-pair position (position), genes at this locus (gene) and surrounding the locus (left and right gene) aswell as feature
of the SNP position within a gene (feature).
Table 3. Meta-analysis results for PC2
SNP Allele 1 Allele 2 Z-score P-value Direction Chr Position Gene Feature Left gene Right gene
rs681524 t c 25.505 3.69E-08 ?------- 11 116253524 SIK3 intron APOA1 LOC100129905
rs1393902 a g 5.119 3.07E-07 ++++++++ 8 68584119 CPA6 intron ARFGEF1 LOC100132812
rs1503369 t c 5.116 3.12E-07 ++++++++ 8 68584552 CPA6 intron ARFGEF1 LOC100132812
rs1827524 a g 5.104 3.32E-07 ++++++-+ 8 68587796 CPA6 intron ARFGEF1 LOC100132812
rs1393901 t c 5.100 3.40E-07 ++++++-+ 8 68587888 CPA6 intron ARFGEF1 LOC100132812
rs6472312 t g 24.994 5.92E-07 ------+- 8 68572052 CPA6 intron ARFGEF1 LOC100132812
rs1503363 a g 24.940 7.80E-07 ------+- 8 68569258 CPA6 intron ARFGEF1 LOC100132812
SevenSNPswere suggestive genome-wide significant (P , 5 × 1027) associatedwith PC2.Top associated SNPs for PC2 are further characterized by corresponding
non-effect allele (allele 1) and effect allele (allele 2), the resultingZ-score and significance of association (P-value). The direction of effect (minus or plus) is indicated
for eachof the eight includedpopulations. If anSNPdid not passQCcriteria for a certainSNP, this is indicatedby a questionmark (?) in thedirection column.Mapping
information for each SNP is specified by chromosome (chr), base-pair position (position), genes at this locus (gene) and surrounding the locus (left and right gene) as
well as feature of the SNP position within a gene (feature).
Table 4. Meta-analysis results for PC3
SNP Allele 1 Allele 2 Z-score P-value Direction Chr Position Gene Feature Left gene Right gene
rs6134479 c g 5.010 5.44E-07 +++++++? 20 12170165 NA NA BTBD3 PA2G4P2
One SNP was suggestive genome-wide significant (P, 5 × 1027) associated with PC3. The top associated SNP for PC3 is further characterized by corresponding
non-effect allele (allele 1) and effect allele (allele 2), the resultingZ-score and significance of association (P-value). The direction of effect (minus or plus) is indicated
for eachof the eight includedpopulations. If anSNPdid not passQCcriteria for a certainSNP, this is indicated by a questionmark (?) in the direction column.Mapping
information for each SNP is specified by chromosome (chr), base-pair position (position), genes at this locus (gene) and surrounding the locus (left and right gene) as
well as feature of the SNP position within a gene (feature).
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from 0.97 to 0.94 (for Carlantino and Friuli Venezia Giulia, re-
spectively). A comparison of genotyping at rs681524 between
the original GWAS and the TwinsUK UK10K whole-genome
sequence gave a genotype concordance rate of 0.99 (Table 6).
In addition, 503 females from the TwinsUK UK10K whole-
genome sequencing sample had completed a hearing test.
A linear regression analysis in this subset confirmed a negative as-
sociation between PC2 and rs681524 genotype (adjusted for age
and twin relatedness) (P ¼ 0.010, beta+SE ¼ 20.33+0.13).
Association analysis with rs681524 by age groups
As our interest lies in age-related hearing impairment, subgroup
analysis of rs681524 by age was performed. Association ana-
lyses were conducted for under 40 years, 40 to 60 years and
older than 60 years. The protective effect of the C allele of
rs681524 was detectable in all three age groups with a mean
effect ranging from 20.117 to 20.386 (Table 7). The largest
effect could be detected in the youngest samples (.40 years)
although this was the smallest sample (Table 7).
Expression analysis of Sik3
Sik3 was highly expressed at all three developmental stages
studied in the mouse: at the day of birth as well as 5 days
postnatal, expression of Sik3 was limited to the tops of the
inner and outer hair cells in the cochlea, non-neuronal cells of
the spiral ganglion, cells in the intermediate layer of the stria vas-
cularis and the perilymph-facing layer of the Reissner’s mem-
brane (Fig. 3). In the stria vascularis, Sik3 was expressed near
blood vessels in the intermediate layer. These cells have previ-
ously been described as macrophage-like melanocytes (25).
At4weeksafterbirth,Sik3expressioncouldno longerbedetected
in thehair cells, indicating that this expressionwas limited toearly
developmental stages. Expression in the spiral ganglion and stria
vascularis remained even 4 weeks after birth (Fig. 3).
To confirmwhether Sik3 expression in the hair cells is limited
to the apex of the hair cells or the stereocilia, confocal imaging of
5-day-old whole-mount sections was performed. Sik3 expres-
sion was found at the top of hair cells in the region around the
base of the stereocilia in both inner and outer hair cells through-
out the cochlea, from base to apex (Fig. 3).
Differential Sik3 expression in the spiral ganglion
We performed a parallel stain of adjacent spiral ganglion
sections at 5 days old with markers specific for Type 1 and 2
spiral ganglion neurones and glial cells. Peripherin is expressed
in type 2 neurones only (26), whereasb-tubulin Tuj1 is expressed
in both type 1 and 2 spiral ganglion neurones (27), and glial
Figure1.Locus zoomplot of the associatedgeneticmarkerson chromosome11q23.3.The locus zoomdepicts the locationof geneticmarkers versus their significance
of association with PC2. Significance of association is measured as the negative logarithm of the P-value. Genes located in the area 400 kb up-and downstream of
rs681524 are displayed below the x-axis. The grey shading of each genetic marker indicates its correlation with the reference SNP rs681524. A legend for the correl-
ation is shown in the upper left corner of the locus zoom. Recombination rate is highlighted as peaked lines.
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fibrillary acidic protein (GFAP) expression is limited to
Schwann and satellite cells in the developing spiral ganglion
(28). The differential staining pattern of the markers was com-
pared with Sik3 expression in the spiral ganglion, and there
was no overlap with either peripherin or beta-tubulin (Fig. 4).
These findings suggest that Sik3 is not expressed in the neurones
themselves, but in surrounding structures. We went on to
compare Sik3 expression with that of GFAP, a marker for glial
cells. GFAP was widely expressed in non-neuronal cells of the
spiral ganglion, whereas Sik3 expression appeared in more
limited numbers of small cells in the spiral ganglion (Fig. 4).
Sik3 appears to be expressed in the cell nucleus, whereas
GFAP is expressed in the cytoplasm and cytoskeleton of non-
neuronal cells. Careful analysis of adjacent sections labelled
with Sik3 and GFAP antibodies suggested that they labelled
partly overlapping populations of non-neuronal/glial cells,
with some cells expressing only Sik3, some only GFAP and
other cells labelled for both proteins (Fig. 4). A similar expres-
sion profile in the spiral ganglion has been reported for oestrogen
receptor-b previously (29).
DISCUSSION
Here, we report results from the largest GWASmeta-analysis on
hearing ability to date, comprising 8 study groups from across
Europe, giving a total sample size of 4939 adults, allowing
phenotype- andpopulation-specific adjustments to beperformed
for each GWAS separately. We have identified a single SNP in
SIK3 (P ¼ 3.7 × 1028) as associated with hearing.
Concern that the finding of the single associated SNP on
chromosome 11 represented a false-positive was addressed in
a number ofways. Examination of the region of interest revealed
an unusual pattern of LD: 1000 Genomes and UK10K data
reflecting genetic variations from 1092 and 2000 genomes,
respectively, were found to be consistent with HapMap CEU
data, with very low LD across the region. Examination of geno-
typing cluster plots (Supplementary Material, Fig. S2) in the
Figure 2. Forest plot for the PC2meta-analysis result for rs681524 in SIK3. The
forest plot shows the effect sizes (beta with 95%CI) at rs681524 on PC2 for each
population incomparisonwitha combinedmeta-analysis effect (total).Aconsist-
ent negative effect for theminorCallele at rs681524 for all Europeanpopulations
could be determined. The percentage of variation owing to heterogeneity across
populations was not significant (I2 ¼ 0.0, P ¼ 0.481). Corresponding data are
listed in Table 5.
Table 5. GWAS and meta-analysis results for rs681524
Population n MAF Imputation quality Beta SE P-value Z-Score
Carlantino 280 0.057 0.458 20.2438 0.2215 0.2710 21.101
Cilento 419 0.075 0.438 20.2206 0.1958 0.2599 21.127
Friuli Venezia Giulia 1097 0.080 0.696 20.1836 0.0728 0.0117 22.522
Korcula 794 0.064 0.523 20.1695 0.1153 0.1415 21.470
Split 497 0.087 0.598 20.4166 0.1276 0.0011 23.265
Silk Road 255 0.039 0.618 20.0579 0.1705 0.7342 20.340
Talana – – – – – – –
TwinsUK 980 0.065 1.00 20.3423 0.0914 1.8E-04 23.745
Total 4322 – – 20.2439 – 3.69E-08 25.505
The GWAS results for each population at rs681524 are characterized by the number of subjects with genotyping or imputation data at this SNP (n), the direction of
effect for theCallele (beta), theMAFof the effect allele, the imputationquality of theSNP, standard error of the direction of effect (SE) and significanceof association
andZ-score calculated for themeta-analysis. The combinedmeta-analysis results are listed asTotal.Agraphical interpretationof this data canbe seen inFigure2. SNP
rs681524 did not pass quality control criteria for the population of Talana.
Table 6. Imputation accuracy at rs681524 in whole-genome sequencing data
Population Genotyping/imputation accuracy
n Genotype concordance
Carlantino 93 0.97
Friuli Venezia Giulia 222 0.94
TwinsUK 2000 0.99
Imputation quality was assessed in two subsamples from Carlantino and Friuli
Venezia Giulia with whole-genome sequencing data available. Imputation
accuracy was measured as genotype concordance rate at rs681524. For
TwinsUK,genotyping data from the originalGWASsamplewere comparedwith
whole-genome sequencing data from the TwinsUK UK10K sample.
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TwinsUK sample revealed clear separation of genotypes at
rs681524. Although this SNP was genotyped in TwinsUK
only, imputation quality of rs681524 passed our quality
control threshold of 0.3 in the other six population samples
(Table 5). Furthermore, imputation accuracy for rs681524 as
determined in subsets fromFriuli Venezia Giulia andCarlantino
with whole genotyping data (n ¼ 222 and 93, respectively)
ranged between 0.94 and 0.97, respectively. The SIK3 SNP
Table 7. Association of rs681524 with hearing PC2 stratified by age groups
Population ,40 years 40–60 years .60 years
n Beta SE n Beta SE n Beta SE
Carlantino 88 20.448 0.613 87 0.468 0.599 105 20.412 0.403
Cilento 82 20.956 0.385 150 20.675 0.282 188 0.105 0.274
Friuli Venezia Giulia 295 0.124 0.116 424 20.518 0.170 378 20.258 0.210
Korcula 103 0.089 0.306 399 0.304 0.183 292 0.349 0.243
Split 138 20.307 0.257 232 20.595 0.218 127 20.263 0.272
Silk Road 115 20.210 0.424 104 0.253 0.428 36 20.027 0.691
Talana NA NA NA NA NA NA NA NA NA
TwinsUK 19 20.993 0.671 372 20.356 0.162 589 20.314 0.113
Mean effect 120 20.386 0.396 253 20.160 0.292 245 20.117 0.315
Theeffect of theCallele at rs681524onhearingPC2was analysed in three agegroups (.40, 40–60and.60 years) in all samples separately.For eachassociation, the
sample size (n), effect size (beta) and standard error of the effect size (SE) are given. A mean effect was calculated for all samples per age group (beta, SE).
Figure 3. Sik3 is expressed in cochlear structures at different developmental stages. Mouse cochlear sections were stained with primary Sik3 antibody (brown) and
counterstainedwith haematoxylin (blue).A,B,E andF: at the day of birth (P0), Sik3 expressionwas detected in the apex of inner and outer hair cells (B, red arrows), in
the perilymph-facing layer of theReissner’smembrane (F, grey arrows), near blood vessels of the intermediate layer of the stria vascularis (F, black arrows), aswell as
in cells of the spiral ganglion (E,white arrows) and cells surrounding the ganglion.C,D,G andH: at 5 days postnatal (P5), Sik3 expressionwas found in the hair cells
(D, red arrows) and small cells of the spiral ganglion (G,white arrows). I andJ: at 4 weeks postnatal, Sik3 expression remained in the spiral ganglion (J,white arrows),
Reissner’smembrane and stria vascularis but couldnot be detected in the apex of the hair cells (I).K,L andM: confocal imagingof Sik3 expression in the stereocilia at
5 days postnatal (L, green), comparedwith Phalloidin expression (K, red) showed that Sik3was expressed in the region around the base of the stereocilia (M,merged
image of K and L). IHCs, inner hair cells; OHCs, outer hair cells. Scale bars: A, C and I: 50 mm; B, D, E, F, G, H and J: 10 mm; K, L and M: 5 mm.
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showed significant genome-wide association with PC2, and the
gene was considered a good candidate for hearing ability
because of the involvement of other salt-inducible kinases
(SIKs) in the inner ear (30). Immunohistochemistry was
performed using mouse cochlea in order to localize expression
of the protein to a single cell type, rather than to the cochlea in
general. Sik3 was found expressed in the apex of the hair cells
of murine cochlea during early development and in non-neural
Figure 4. Sik3 is expressed in small cells between the neurones of the spiral ganglion. To identify the cell type expressing Sik3 in the spiral ganglion, Sik3 expression
was comparedwith beta-tubulin (A andD), Peripherin (C andF) and GFAP (G and I) expression in adjacent sections. Beta-tubulin is expressed in both Type 1 and 2
spiral ganglion neurones, whereas peripherin expression is limited to type 1 spiral ganglion neurones. Sik3 expression (B and E) did not coincide with either beta-
tubulin (A and D) or peripherin expression (C and F) but seemed to be expressed in smaller cells interspersed between the neurones. To determine whether Sik3
couldbe expressed in glial cells, Sik3 expression (H andJ)was comparedwithGFAPexpression (Gand I) in adjacent sections. Sik3 andGFAPexpression overlapped
partially. Sik3expressioncoincidedwithGFAPexpression in somecells (blackarrows)butwas absent inother glial cells (red arrows).All sectionswereprepared from
mice at 5 days postnatal (P5). Expression of each antibody is indicated by a brown signal. Scale bars: A, B, C, D, E, F, I and J: 10 mm; G, H: 50 mm.
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cells of the spiral ganglion throughout development and adult-
hood. Furthermore, it was expressed in macrophage-like mela-
nocytes in the stria vascularis and perilymph-facing cells at
the Reissner’s membrane. Confocal microscopy confirmed the
expression of Sik3 at the apex of the hair cells around the
bases of the stereocilia of 5-day-old wild-type mice. Expression
of Sik3 in the apex of the hair cells was limited to early stages of
development. Mouse pups are born deaf and develop the ability
to hear at aroundDay 12 (31). Our data suggest that Sik3may be
important for hair cell or stereocilia development but is not
required for the maintenance of these structures in adulthood.
In contrast, Sik3 was consistently expressed in spiral ganglia
throughout all developmental stages. The striking expression
ofSik3 in themurine cochlea supports a role duringdevelopment
and maintenance of the inner ear.
We compared the expression of Sik3 with that of molecular
markers for Type 1 and Type 2 spiral ganglion neurones and
glial cells. Sik3 expression in the spiral ganglion did not overlap
with neurones but with smaller, distinct cells interspersed be-
tween them. Comparison of Sik3 and GFAP, a marker for glial
cells, in adjacent cochlear sections showed Sik3 limited to the
nucleus of labelled cells, whereas GFAP was expressed in cyto-
plasmic structures of non-neuronal cells of the spiral ganglion.
Sik3 andGFAPexpression overlappedpartially in the spiral gan-
glion. In conclusion, Sik3 is expressed in non-neuronal cells of
the spiral ganglion, which we assume to be an undefined sub-
group of glial cells.
SIKs belong to the family of cAMP-activated serine threonine
kinases (32). Three family members have been described so far
(32), and isoforms 1 and 2 have been the main focus of research.
Sik1 and 2 show high expression in adrenal glands of mice on
a high sodium diet, thus the name “salt-inducible” kinases,
whereas Sik3 was reported to be expressed ubiquitously (32).
Sik1 has been linked to various processes, including sodium
sensing and cardiomyogenesis (33,34). In addition, Sik1 has
been shown to be expressed in the inner ear, in the sensory epi-
thelium of the vestibular system, where it is thought to be
involved in the formation of hydrops via interaction with phos-
phodiesterases (30).Both Sik1 andSik3 control histone deacety-
lases via phosphorylation and nuclear export (35–37). Sik3
knockoutmice (Sik32/2) have a highmortality rate at birth. Sur-
viving pups show skeletal abnormalities, reduced bodyweight
and dwarfism, but no details of their hearing ability have been
reported yet. Sik32/2 mice show reduced energy storage,
which is associated with hypoglycaemia and hyper-insulin sen-
sitivity. Lipidmetabolism disorders in (Sik32/2) micewere par-
tially restored after 9-cis-retionic acid supplementation (38).
Sik3 is assumed to regulate cholesterol bile acid homeostasis
and lipid storage size and is essential for chondrocyte hyper-
trophy (36,38). In addition, SIKs have recently been shown to
be involved in the formation of regulatory macrophages (39).
Salt-inducible kinases were responsible for phosphorylation of
the CREB-regulated transcriptional co-activator 3 and could
therefore inhibit the formation of regulatory macrophages from
proinflammatorymacrophages (39). It appears that Sik3may act
as an important regulator in various body systems, and any of the
above roles of Sik3 could affect the long-term maintenance and
function of the auditory system. From our findings, the Sik3
expression pattern in the mouse inner ear suggests that it is
important during development of hair cells but less so for the
maintenance of these sensory structures. Furthermore, expres-
sion data in mice suggested a maintenance function of Sik3 in
cells of the spiral ganglion. Examining hearing function over
time in Sik3 knockout mice will be essential to understand
fully the function of Sik3 in hearing ability and to give more
detail about putative mechanistic links.
A subset of the samples used in this GWASmeta-analysis had
been used previously in a GWAS meta-analysis of hearing func-
tion (17). In the present study, we included two further studies
of hearing function, one a population sample situated along the
Silk Road (Azerbijan, Giorgia, Kazakistan, Tajikistan, Uzbeki-
stan)(20) and the other a large sample of females from the
TwinsUKcollection.By increasing the sample size, and therefore
statistical power, it was hoped to determine associations with
hearing of genome-wide significance. In comparisonwith the pre-
viously performed meta-analysis, the overlap of significant asso-
ciations was limited. The association of rs681524 has not been
reported in the previous study, which is consistent with the
finding that this association was strongly supported by the
newly added TwinsUK GWAS (Table 5, P-value (TwinsUK) ¼
1.8 × 1024). Furthermore, theprevious study reported suggestive
significant associations with metabotropic glutamate receptor
type 8 (PC1, P-value ¼ 3.22 × 1027); the PBX/knotted homeo-
box 2 gene (PC2, P-value ¼ 2.86× 1027) and phosphatidic
acid phosphatase type 2D (PC3, P-value ¼ 2.32 × 1027) (17).
The association between PC1 and SNPs in the vicinity of GRM8
was confirmed in the present study (rs2687481, P ¼ 1.07 ×
1027), whereas the association we report here between PC1 and
intronic SNPs in Immunoresponsive 1 homologue (IRG1,
rs589636, P ¼ 6.61 × 1028) has not been described previously.
Furthermore, the association of PC2 with carboxypeptidase A6
(CPA6, rs1393902, P ¼ 3.07× 1027) was a novel one. It is
perhaps not surprising that the inclusion of two additional groups
with differing ethnic backgrounds (Silk Road and TwinsUK)
might change the overall significance of associations previously
described in a more homogeneous collection of Southern Euro-
pean samples. The different results may simply indicate that the
populations studied had differing contributions of genome var-
iants to their hearing ability.
There are a number of limitations to this study. The threshold
of significance used here (P ≤ 5 × 1028) does not take into
account the use of PCs providing three phenotypes (PC1, PC2
and PC3) (50). After a strictly conservative adjustment by
Bonferroni, a significance threshold of P ≤ 1.7 × 1028 would
have been required to claim genome-wide significance, which
was not reached in this study. However, despite being statistical-
ly independent phenotypes, all three PCs were derived from the
same single measure of hearing ability.
Replication of the effect of SIK3 rs681524 genotypes on
hearing function would be useful. The samples included in this
meta-analysis were of different ethnic populations, which in-
creases the risk of population stratification. To adjust for this,
population sub-structure was controlled for in the GWAS per-
formed for each sample separately. Different ethnic back-
grounds should also be considered when determining LD
patterns of meta-analysis results. The LD pattern displayed in
the locus zoom plot was based on LD as observed in the
HapMap CEU population; however, this might not represent
the LD pattern in some of the isolated populations studied
here. We compared allele frequencies for the respective SNP
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in data from the Human Genome Diversity project (22) and
found no significant differences in allele frequencies at
rs681524 for the population presented here. The age range for
the cohorts was very broad (18–98 years), and it did vary
between the study groups, with the mean age of the samples
(41.6–61.1) varying by 20 years. However, PCs were adjusted
for age at hearing test prior to the GWAS. In addition, an associ-
ation analysis stratified by age confirmed a consistent effect of
the rs681524 across the age ranges that were largest in those
under 40 years (Table 7). Although genotyping, imputation
and GWA were performed for each cohort separately (Supple-
mentary Material, Table S1), all analyses were conducted
according to predefined protocols, to allow the use of the associ-
ation results inmeta-analysis and the direction of effect adjusted
if necessary owing to differences in direction of PC loadings.
Previous studies reported a gender difference in hearing ability
particularly for older individuals (40). To control for possible
gender differences in hearing ability, we adjusted for this in
the GWAS of the mixed gender cohorts (all but TwinsUK). Fur-
thermore, PCs rather than standard measures of hearing ability
(i.e. pure-tone averages) were used to capture hearing ability.
PCs might be more complex in their interpretation in respect to
hearing, but they enable representation of both overall threshold
shift and slope of the audiogram. In addition, PCs have been
applied to capture pure-tone audiograms previously (14,17).
In conclusion, this study reports the findings of the largest
meta-analysis of hearing function to date. The results suggest
that SIK3 is significantly associated with hearing ability in
humans and expression work in mice supports a role for the
expressed protein in cochlear function.
MATERIALS AND METHODS
Subjects
All samples included in this analysis were from the G-EAR con-
sortium or TwinsUK (www.twinsuk.ac.uk). Both collections
have been described in depth elsewhere (17,41). While
samples from the G-EAR consortium were recruited from
several isolated villages, TwinsUK samples were recruited as
same-sex twin pairs of .18 years of age and resident in the
UK. The specific TwinsUK sample presented here represents a
subsample recruited to study ageing traits in females. Subjects
from the Silk Road originate from five countries situated along
the Silk Road (Azerbijan, Giorgia, Kazakistan, Tajikistan,
Uzbekistan), which were combined as one cohort. Participants
underwent a standard pure-tone audiogram according to recom-
mendations by the local authorities (e.g. British Society ofAudi-
ology (42) for TwinsUK) and gave blood or saliva samples for
DNA extraction. Participants with a reported family history of
HL or previous ear diseases causing conductive HL were ex-
cluded from the analysis. All samples were recruited to represent
hearing function in the population. All research was conducted
according to the ethical standards as defined by the Helsinki dec-
laration. The study was approved by the Institutional Review
Board of IRCCS-Burlo Garofolo, Trieste, Italy and the National
Research Ethics service London-Westminster (REC reference
number: 07/H0802/84) as well as by the other involved
members. Fully informedwritten consent was obtained from par-
ticipants prior to their inclusion in the study.
Phenotypes
Principal components were calculated from pure-tone thresh-
olds measured in decibel hearing level (dB HL) (250, 500,
1 kHz, 2, 4 and 8 kHz) as previously described (14). While
PCs for samples from TwinsUK, Korcula and Split were based
on hearing thresholds for the better ear, PCA was conducted
for the left and right ear separately in the remaining samples
and the PC value for better ear selected afterwards. Eigenvector
loadings for the different frequencies and PC eigenvalues for the
different samples can be found in Supplementary Material,
Table S3. The PCs represented the overall horizontal threshold
shift, high-frequency slope and concavity of the audiogram,
respectively, as described elsewhere (14). The size of PC1
gives information about the overall change in pure-tone thresh-
olds, whereas PC2 is more sensitive to the slope in the audio-
gram, as seen for high-frequency sensorineural HL. PC1 is
positively correlated with good hearing. Therefore, a high PC1
value represents overall low pure-tone thresholds (good
hearing ability), whereas a low PC1 value indicates raised pure-
tone thresholds over all frequencies (HL). PC2 was positively
correlated with a high-frequency HL, with a high PC2 value
representinga slopingaudiogramanda lowPC2value indicating
a flat, non-sloping audiogram. These conclusions were obtained
by comparison of audiogram shapes between subjects with high,
medium and low PC values for each PC1–3. Principal compo-
nents were calculated separately for each cohort and adjusted
for age and gender using linear regression. Age- and gender-
adjusted residuals forPC1, 2 and3were rank-transformed tonor-
mality and used as traits for hearing ability. Direction of effect
was adjusted prior to meta-analysis by taking the reverse of the
effect if the direction of the PC loadings were of opposite direc-
tion between samples.
Genotyping
Participants from theG-EAR consortiumwere genotyped on the
Illumina 370 k chip or on the Affymetrix 500 k genotyping
array. Genotyping and imputation were performed separately
for each population. Subjects from the TwinsUK cohort were
genotyped on either Illumina HumanHap300 Bead Chip or Illu-
minaHumanHap610QuadChip (41).Genotype callingwas per-
formed using the appropriate software and imputed to the
HapMap Phase 2 CEU sample. Genotyped SNPs were excluded
from further analysis based on minor allele frequency (MAF),
call rate and significance of violation from Hardy–Weinberg
equilibrium (pHWE). Exact quality control measures applied
for each population are shown in Supplementary Material,
Table S1.
Imputation
Imputation was performed separately for each of the eight popu-
lations based on haplotypes of the CEU Hapmap Phase II refer-
ence population. Populations from the G-EAR cohort (Italy,
Croatia and Silk Road) were imputed using MACH 1.0
(Markov Chain-based haplotyper) (43,44), for TwinsUK using
Impute version 2 (45). Imputed SNPs with a quality score of
,0.4 (info in Impute versus 2) or 0.3 (Rsq in MACH 1.0),
respectively, were excluded from the meta-analysis.
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Meta-analysis/statistical analysis
GWAS was run by each group using age- and gender-adjusted
rank-transformed PC residuals. In the GWAS, a linear mixed-
model regression was performed, assuming an additive genetic
model. Owing to the increased relatedness of samples in the iso-
lated populations and the twin sample presented here, related-
ness was accounted for by inclusion of a kinship matrix in the
polygenic model. This was performed using the GRAMMAR
option (46) available for mmscore in Genabel (47). A compari-
son of three samples of related subjects has shown this option
to be similar in power and type 1 error to using Genomic
Control (48). In addition, for TwinsUK, population outliers (as
determined by ancestry PCs) were excluded prior to analysis.
Association analysis was performed for each of the eight
samples separately.
Themeta-analysis was performed by two centres independent-
lyusingMETAL(49), basedon theweightedZ-score option. This
method calculates a signed Z-score dependent on theP-value and
direction of effect per allele per population. Z-scores for each
allele and sample were weighted according to the sample size
andsummedtogiveacombinedscore.ExtremeZ-scores (positive
or negative) indicate a small P-value, whereas a positive score
indicates increased, and a negative score a decreased disease
risk (49).Meta-analysis was performed for PC1–3. The direction
of effect (beta) for each sample and corresponding standard errors
of the top associated genetic markers with PC2 are presented in
plot (Fig. 2, with corresponding data in Table 5). AnMAF thresh-
old of ≥ 0.01, call rate of ≥0.90 and p(HWE) of ≥1026 was
applied in themeta-analysis. The combined betaswere calculated
as a summary measure of the separate population betas weighted
by sample size of each population. LD information 500 kb up-and
down-streamof rs681524was extracted fromtheSNPAnnotation
and Proxy Search tool (24) using the 1000 Genomes pilot 1, CEU
populationdataset (n ¼ 1092) (23)and theTwinsUKsample (n ¼
5654) newly imputed based on the whole-genome sequencing
data from the UK10K TwinsUK cohort sample (n ¼ 2000).
In addition to the TwinsUK sample, two further samples (Car-
lantino and Friuli Venezia Giulia) had whole genotyping data
available in a subset (n ¼ 93 and 222, respectively) (Table 6)
and imputation accuracy was assessed in these populations.
For TwinsUK, genotyping data from the original GWAS sample
were compared with whole-genome sequencing data from the
TwinsUK UK10K sample (Table 6).
Analysis by age groups
The effect of the C allele at rs681524 on hearing was analysed in
three age groups (.40, 40–60 and .60 years) in all samples
separately. The association analyses were conducted adjusted
for relatedness between subjects, as described earlier. PC
values used in this analysis were not adjusted for age of subjects.
A mean effect was calculated for all samples per age group
(Table 7).
Immunohistochemistry for Sik3
Mouse studies were carried out in accordance with UK Home
Office regulations and the UK Animals (Scientific Procedures)
Act of 1986 (ASPA) under a UK Home Office license, and
the study was approved by the Wellcome Trust Sanger Insti-
tute’s Ethical Review Committee. Mice were culled using
methods approved under this license tominimize any possibility
of suffering.
Wild-type C57Bl/6 mice homozygous for a spontaneous
albino mutation were sacrificed at three different steps of devel-
opment, the day of birth (P0), postnatal day 5 (P5) and at the age
of 4 weeks. Mouse heads were fixed in 10% formalin at 48C for
48 h, followed by two washing steps of 30 min in phosphate-
buffered saline (PBS). For decalcification, 4-week-old speci-
mens were kept in 10% ethylenediaminetetraacetic acid in
PBS for 2.5 days at 48C. Following the decalcification, tissues
were washed in PBS (2 × 30 min at room temperature) and
saline (2 × 2 h at 48C). To dehydrate the samples, a dehydration
chain of increasing ethanol concentration was used at 48C.
Tissues were embedded overnight and mounted in paraffin wax
the following morning. Serial 8-mm sections were mounted on
glass slides and dried at 408Covernight. Immunohistochemistry
was performed by the Ventana Discovery system (Ventana
Medical Systems, Inc. Illkirch, France) according to the manu-
facturer’s instructions.
For each age, between three and sixmice andmultiple sections
per animal were analysed and observations only reported if all
samples showed similar labelling patterns. Two separate Sik3
antibodies were used, and both gave identical labelling, support-
ing the validity of the expression patterns detected. Control sec-
tions were prepared omitting the primary antibody, and these
showed no noticeable labelling.
Antibodies
The following primary antibodies were used for immunohisto-
chemistry experiments: primary Anti-SIK3 antibody (ab110987,
Abcam,Cambridge,UK, and as a control: LS-c120369SIK3Life-
spanBioscience,Seattle,USA)at1 : 50(P0,P5)or1 : 40 (4weeks)
concentration; anti-peripherin antibody (ab4666, Abcam, Cam-
bridge, UK) at a 1 : 100 concentration; anti-TUJ1 antibody
(Covance, New Jersey, US) at a 1 : 100 concentration; anti-
GFAP antibody (ab53554, Abcam, Cambridge, UK) at a 1 : 50
concentration. The secondary antibody, biotin-conjugated
donkey anti-rabbit (711-065-152), was purchased from Jackson
ImmunoResearch (West Grove, PA, USA). Images of the anti-
body stained sections were taken using a Zeiss Axioskop MOT
light microscope. Image processing was performed in Adobe
Photoshop CS5.
Confocal microscopy
Heads from 5-day-old mice (P5) were bisected, and inner ears
plus bone were removed from the skull and then fixed in 4%
paraformaldehyde for 2 h at room temperature. Subsequently,
specimens were fine-dissected in PBS, then washed and per-
meabilized in 1% PBS/Triton X-100 (PBT) and blocked with
10% sheep serum. Then, they were incubated with the primary
antibody, rabbit polyclonal against Sik3 (ab110987, Abcam,
Cambridge, UK, dilution 1 : 200) overnight at 48C. After
washes with PBT, samples were incubated with anti-rabbit
Alexa Fluor 488 secondary antibody (Invitrogen, anti-rabbit,
diluted 1 : 500) and rhodamine/phalloidin (Invitrogen, diluted
1 : 100). Samples were mounted in Prolong Gold Antifading
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reagent (Invitrogen). Images were acquired on a LSM 510Meta
confocal microscope (Zeiss, Welwyn Garden City). Image pro-
cessing was performed in Adobe Photoshop CS5.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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